Synaptixbio
synaptixbio.com
Health Care
Rare Disease Therapeutics
Biotechnology
Claim pageClaim
Follow
Overview
Connections
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Latest round
Venture round
Jul 2024 · 2 yr ago
Team
51-200
employees, estimated range
Grants
$3.2M
2 grants · CORDIS
The money's age
Long since its last round
27 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 4, 2024
Raised a round Venture round
Jul 1, 2024
Won a grant $2.5M · CORDIS
Nov 1, 2023
Won a grant $633k · CORDIS
Apr 26, 2023
Raised a round Venture round
May 4, 2022
Raised a round Venture round
Apr 7, 2021
Founded per the company register
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jul 2024 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Jul 2024 | $2.5M | — | CORDIS |
| Grant | Nov 2023 | $633k | — | CORDIS |
| Venture round | Apr 2023 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | May 2022 | — | — | find-and-update.company-information.service.gov.uk |
Registers and programsofficial lists and records that name the company
| Legal entity | SYNAPTIXBIO LTD | Companies House |
| Registered | 7 Apr 2021 |
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Mendra is a venture-backed rare-disease biopharma accelerating the development and commercialization of de-risked breakthrough therapies.
Explore the Kyntra Bio site to learn about our oncology and rare disease therapies, pipeline highlights, clinical trials, culture, and…
US FDA Grants Orphan Drug and Rare Pediatric Disease Designations to GEn1E Lifesciences' Dual Signal Modulator for the Treatment of…
NBO (acronym for Nasal Bioavailability of Octreotide) Pharma Inc. was incorporated in 2021 to develop a drug for the treatment of…
Eton is an innovative pharmaceutical company that searches the world over for meaningful therapies that we can bring to patients living…
Sidewinder Therapeutics is pioneering the next generation of large molecule precision therapeutics. We aim to deliver new life-saving…
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Oxford
United Kingdom
HQ
50-200 est. staff